SRR627429
GTEX
Clinical attributes
From the source cohort, normalized into canonical keys plus the project's native columns.
- cancer_type
- GTEX
- cancer_type_detailed
- —
- subtype
- —
- cancer_type
- GTEX
- sex
- Female
GSVA pathway preview (50 Hallmark scores)
Top 10 most elevated and top 10 most suppressed Hallmark pathways for this sample.
Top 10 elevated
- SPERMATOGENESIS+0.193
- UV_RESPONSE_DN+0.150
- KRAS_SIGNALING_DN+0.121
- MITOTIC_SPINDLE+0.107
- G2M_CHECKPOINT+0.087
- PROTEIN_SECRETION-0.013
- PANCREAS_BETA_CELLS-0.078
- ANDROGEN_RESPONSE-0.079
- BILE_ACID_METABOLISM-0.088
- APICAL_SURFACE-0.121
Top 10 suppressed
- REACTIVE_OXYGEN_SPECIES_PATHWAY-0.527
- OXIDATIVE_PHOSPHORYLATION-0.510
- INTERFERON_ALPHA_RESPONSE-0.473
- MYC_TARGETS_V2-0.452
- MYC_TARGETS_V1-0.451
- ADIPOGENESIS-0.443
- TNFA_SIGNALING_VIA_NFKB-0.439
- DNA_REPAIR-0.436
- APOPTOSIS-0.426
- UV_RESPONSE_UP-0.424
Patient twins — nearest pathway neighbors
10 samples closest to this one in 50-dim pathway space, drawn from the Pathway Atlas. Cosine similarity = 1 means identical pathway state.
10 twins match this tumor's tissue · 0 come from a different tissue of origin
| # | Sample | Cancer type | Subtype | cos similarity |
|---|---|---|---|---|
| 1 | SRR627451 | GTEX | — | 0.990 |
| 2 | SRR627462 | GTEX | — | 0.986 |
| 3 | 62454053-936d-4f19-8522-6219c47bdd1c | — | — | 0.953 |
| 4 | e356598b-7611-492a-98ed-ef2ec1b77b7a | — | — | 0.951 |
| 5 | SRR627455 | GTEX | — | 0.949 |
| 6 | ed8896f8-24ef-43a4-ace6-ed9353bd11c2 | — | — | 0.948 |
| 7 | b8135e73-31c3-49af-b4da-a7ed5f28d68a | — | — | 0.941 |
| 8 | SRR1455060 | GTEX | — | 0.936 |
| 9 | SRR627299 | GTEX | — | 0.928 |
| 10 | TCGA-A7-A0DB-01C-02R-A277-07 | — | D | 0.922 |
Per-pathway drug coverage
For each elevated pathway in this tumor, the best-reversing drug across the catalog. Uncovered pathways = unmet need at pathway level for this one patient.
0 of 5 elevated pathways have at least one drug that meaningfully reverses them.
| Pathway (elevated) | tumor score | Best drug | reversal magnitude |
|---|---|---|---|
| SPERMATOGENESIS | 0.193 | Inavolisib | — uncovered |
| UV_RESPONSE_DN | 0.150 | Inavolisib | — uncovered |
| KRAS_SIGNALING_DN | 0.121 | Remibrutinib | — uncovered |
| MITOTIC_SPINDLE | 0.107 | Inavolisib | — uncovered |
| G2M_CHECKPOINT | 0.087 | Inavolisib | — uncovered |